Obtaining Paediatric SPC Extensions in the European Union
This article was originally published in SRA
New European Union legislation on paediatric data requirements for marketing authorisation applications came into effect in January 2007. Among other things, the so-called Paediatric Regulation offers a reward for conducting paediatric trials: a six-month extension to the supplementary protection certificate. In this article, we look at the details of the regulation (Regulation (EC) No 1901/2006)1, how companies should go about gaining the SPC extension and some of the pitfalls they may encounter along the way.
You may also be interested in...
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.